Literature DB >> 27302708

A Brief Assessment for HIV Risk: The TCU HVHP Form.

Grace A Rowan1, George W Joe2, Wayne E K Lehman2, Kevin Knight2.   

Abstract

Targeted HIV screens may help identify some risk-related concerns of drug-using offenders. The present study describes the Texas Christian University HIV/Hepatitis Risk Assessment (TCU HVHP) form, a 19-item self-report instrument measuring HIV and hepatitis risks based on a sample (N = 1,056) of offenders in eight prisons. Principal components analysis indicated four scales (Injection Risk, Condom Attitudes, Sex Risk, and AIDS Concern) with reliable psychometric properties with coefficient α reliabilities ranging from .72 to .88. Concurrent validities indicated the four scales were related to motivation for treatment, level of drug use, psychosocial functioning, and criminal thinking, although the patterns varied by gender. The TCU HVHP Form should be attractive to programs needing a brief assessment measuring HIV risk behaviors, attitudes toward condom use, and concerns about acquiring and transmitting HIV.
© The Author(s) 2016.

Entities:  

Keywords:  HIV; gender; hepatitis; offenders; screening

Mesh:

Year:  2016        PMID: 27302708      PMCID: PMC5080836          DOI: 10.1177/1078345816653871

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  26 in total

1.  Psychometric properties of the PTSD Checklist (PCL).

Authors:  E B Blanchard; J Jones-Alexander; T C Buckley; C A Forneris
Journal:  Behav Res Ther       Date:  1996-08

2.  Drug-abusing offenders with co-morbid mental disorders: gender differences in problem severity, treatment participation, and recidivism.

Authors:  Jiang Du; David Huang; Min Zhao; Yih Ing Hser
Journal:  Biomed Environ Sci       Date:  2013-01       Impact factor: 3.118

3.  Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness.

Authors:  Stanley D Rosenberg; Richard W Goldberg; Lisa B Dixon; George L Wolford; Eric P Slade; Seth Himelhoch; Gerard Gallucci; Wendy Potts; Stephanie Tapscott; Christopher J Welsh
Journal:  Psychiatr Serv       Date:  2010-09       Impact factor: 3.084

4.  Risky relationships: targeting HIV prevention for women offenders.

Authors:  Carl Leukefeld; Jennifer Havens; Michele Staton Tindall; Carrie B Oser; Jennifer Mooney; Martin T Hall; Hannah K Knudsen
Journal:  AIDS Educ Prev       Date:  2012-08

5.  Differences between men and women in condom use, attitudes, and skills in substance abuse treatment seekers.

Authors:  Donald A Calsyn; Michelle Peavy; Elizabeth A Wells; Aimee N C Campbell; Mary A Hatch-Maillette; Shelly F Greenfield; Susan Tross
Journal:  Am J Addict       Date:  2013 Mar-Apr

6.  Texas Christian University (TCU) Short Forms for Assessing Client Needs and Functioning in Addiction Treatment.

Authors:  D Dwayne Simpson; George W Joe; Kevin Knight; Grace A Rowan-Szal; Julie S Gray
Journal:  J Offender Rehabil       Date:  2012-03-07

7.  Relationship influence and health risk behavior among re-entering women offenders.

Authors:  Michele Staton-Tindall; Linda Frisman; Hsui-Ju Lin; Carl Leukefeld; Carrie Oser; Jennifer R Havens; Michael Prendergast; Hilary L Surratt; Jennifer Clarke
Journal:  Womens Health Issues       Date:  2011-02-11

8.  Incarceration and risky sexual partnerships in a southern US city.

Authors:  Maria R Khan; David A Wohl; Sharon S Weir; Adaora A Adimora; Caroline Moseley; Kathy Norcott; Jesse Duncan; Jay S Kaufman; William C Miller
Journal:  J Urban Health       Date:  2007-11-20       Impact factor: 3.671

9.  Validation of the PTSD checklist in an HMO sample of women.

Authors:  Edward A Walker; Elana Newman; Dorcas J Dobie; Paul Ciechanowski; Wayne Katon
Journal:  Gen Hosp Psychiatry       Date:  2002 Nov-Dec       Impact factor: 3.238

10.  Brief Trauma and Mental Health Assessments for Female Offenders in Addiction Treatment.

Authors:  Grace A Rowan-Szal; George W Joe; Norma G Bartholomew; Jennifer Pankow; D Dwayne Simpson
Journal:  J Offender Rehabil       Date:  2012-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.